(Reuters) - For decades, scientists have been working to develop medical therapies from the body's own stem cells. Promising new treatments are finally moving through clinical trials in conditions ranging from heart disease and inflammation to eye diseases and diabetes. While it is too early to predict winners, here are some of the programs that are likely to attract attention in the coming years: * Aastrom Biosciences Inc is due to start a Phase III trial of its treatment for critical limb ischemia, a severe form of peripheral artery disease. ...
0 comments:
Post a Comment